The SEAPORT 1 Study: Evaluation of the Safety and Tolerability of INZ-701 in Adults With End-Stage Kidney Disease Undergoing Hemodialysis
Clinical trial NCT06283589 · COMPLETED
Trial details
- NCT number
- NCT06283589
- Sponsor
- Inozyme Pharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-12
- Primary completion
- 2024-07-27
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.